Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Phase I trial: Quotient code QSC301813

Phase I trial: Quotient code QSC301813

Recruiting

Open to: All Genders

Age: Adult

Medical Conditions

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

16 Sep 2024 29 Jan 2025

Interventional

Intervention Type : Drug
Intervention Description : The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.




You can take part if:



You may not be able to take part if:


The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Quotient Sciences Limited
    Mere Way Ruddington Fields Ruddington
    Nottingham
    NG11 6JS

This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.


The study is sponsored by Carmot Therapeutics (United States) and funded by Carmot Therapeutics, Inc..




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN90651766
Last updated 25 September 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.